by Pauline Lauterbach | Jan 16, 2026 | Completed, For participants
ABTECT-1 Study on Ulcerative Colitis A recent study tested ABX464, a new drug for people with moderate to severe ulcerative colitis who have not responded to standard treatments. Participants received either ABX464 or a placebo to determine if the drug can alleviate...
